Search
for
Sort by
Research 961–990 of 1000+
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Microneedles along with conventional therapies: An in-depth observational review in alopecia areata treatment
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Editorial: Targeted immunological therapies in dermatology
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Human hair regeneration using organoids and hair-on-chip technologies
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Understanding autoimmunity of vitiligo and alopecia areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Frontiers in alopecia areata pathobiology research
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Sprayable biomimetic double mask with rapid autophasing and hierarchical programming for scarless wound healing
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Protein degradation: expanding the toolbox to restrain cancer drug resistance